CNO FINANCIAL GROUP INC (CNO) 25.31 -0.16 (-0.63%)
25.31 -0.16 (-0.63%)
US12621E1038 - Common Stock
Buy % Consensus
Analysts have set a mean price target of 24.31. This target is -3.95% below the current price.
CNO was analyzed by 10 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about CNO.
In the previous month the buy percentage consensus was at a similar level.
CNO was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-01-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-17 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-02 | RBC Capital | Maintains | Outperform |
| 2022-10-07 | Piper Sandler | Maintains | Neutral |
| 2022-09-13 | RBC Capital | Initiate | Outperform |
| 2022-07-08 | Piper Sandler | Maintains | Neutral |
| 2022-07-06 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-27 | Piper Sandler | Maintains | Neutral |
| 2022-05-03 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-04-08 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-01-26 | Jefferies | Initiate | Hold |
| 2022-01-07 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-01-05 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2021-09-10 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2021-04-01 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-03-31 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2021-02-25 | Morgan Stanley | Maintains | Equal-Weight |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA